Page last updated: 2024-12-06

9-hydroxybenzo(a)pyrene

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

9-Hydroxybenzo(a)pyrene (9-OH-BaP) is a metabolite of the potent carcinogen benzo(a)pyrene (BaP), a polycyclic aromatic hydrocarbon (PAH) found in environmental sources such as cigarette smoke and diesel exhaust. 9-OH-BaP is formed through the action of cytochrome P450 enzymes, which are involved in the detoxification of foreign compounds in the body. However, in the case of BaP, this metabolic process can result in the formation of more toxic and reactive metabolites like 9-OH-BaP. 9-OH-BaP is a highly reactive electrophile that can bind to DNA, leading to mutations that can contribute to the development of cancer. Studies have shown that 9-OH-BaP is particularly carcinogenic to the skin, lungs, and digestive tract. The formation and carcinogenic activity of 9-OH-BaP are of significant interest to researchers studying the mechanisms of PAH-induced carcinogenesis. The study of 9-OH-BaP helps to understand the role of metabolic activation in the development of cancer, identify potential targets for cancer prevention and treatment, and develop methods for assessing environmental exposure to PAHs.'

9-hydroxybenzo(a)pyrene: RN given refers to unlabeled parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID28598
CHEMBL ID351406
CHEBI ID34512
SCHEMBL ID3348130
MeSH IDM0076050

Synonyms (23)

Synonym
9-hydroxy benzo[a]pyrene
BIDD:ER0395
benzo(a)pyren-9-ol
9-hydroxybenzo(a)pyrene
benzo(a)pyrene, 9-hydroxy-
ccris 1073
brn 1980310
9-hydroxybenzo[a]pyrene
17573-21-6
9-hydroxy benzopyrene
FT-0669411
CHEMBL351406
benzo[def]chrysen-9-ol
chebi:34512 ,
benzo[a]pyren-9-ol
9-hydroxybenzo(a)pyrene, 3h-labeled
SCHEMBL3348130
DTXSID20170012
AKOS027321432
benzo[pqr]tetraphen-9-ol
Q26841132
STARBLD0000358
pentacyclo[10.6.2.0?,?.0?,??.0??,??]icosa-1(18),2(7),3,5,8,10,12,14,16,19-decaen-4-ol

Research Excerpts

Pharmacokinetics

ExcerptReferenceRelevance
" Combining data for all lobsters, the average terminal elimination half-life of parent 9-OH-BaP was 97."( Oral bioavailability and pharmacokinetics of elimination of 9-hydroxybenzo[a]pyrene and its glucoside and sulfate conjugates after administration to male and female American lobsters, Homarus americanus.
James, MO; Li, CL, 2000
)
0.31

Bioavailability

ExcerptReferenceRelevance
" The oral bioavailability of parent 9-OH-BaP, calculated from the area under the hemolymph concentration curve, was 15."( Oral bioavailability and pharmacokinetics of elimination of 9-hydroxybenzo[a]pyrene and its glucoside and sulfate conjugates after administration to male and female American lobsters, Homarus americanus.
James, MO; Li, CL, 2000
)
0.31
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
ortho- and peri-fused polycyclic arene
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (5)

Assay IDTitleYearJournalArticle
AID624609Specific activity of expressed human recombinant UGT1A62000Annual review of pharmacology and toxicology, , Volume: 40Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
AID624611Specific activity of expressed human recombinant UGT1A82000Annual review of pharmacology and toxicology, , Volume: 40Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
AID624613Specific activity of expressed human recombinant UGT1A102000Annual review of pharmacology and toxicology, , Volume: 40Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
AID160321Competition for [3H]benzo[a]pyrene-binding site of polycyclic aromatic hydrocarbon binding protein (PBP) from mouse liver1990Journal of medicinal chemistry, Feb, Volume: 33, Issue:2
Voronoi binding site model of a polycyclic aromatic hydrocarbon binding protein.
AID624619Specific activity of expressed human recombinant UGT2B72000Annual review of pharmacology and toxicology, , Volume: 40Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (20)

TimeframeStudies, This Drug (%)All Drugs %
pre-199011 (55.00)18.7374
1990's6 (30.00)18.2507
2000's3 (15.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.01

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.01 (24.57)
Research Supply Index3.09 (2.92)
Research Growth Index4.10 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.01)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (9.52%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other19 (90.48%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]